JAMA 332 , 571584 (2024)
Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR
Its shape now looks like a tube, banana or sleeve that restricts the amount of food consumption
Konieczne s dalsze badania, szczeglnie na wikszych grupach pacjentw, aby w peni potwierdzi bezpieczestwo i skuteczno Epithalonu w dugoterminowym stosowaniu
In addition to lowering blood glucose levels, GLP-1RAs can increase satiety, promote weight loss, and offer potential cardiovascular protection
The medication is administered once daily via subcutaneous injection, with doses gradually increased over five weeks to the maintenance dose of 3.0 mg to minimise gastrointestinal side effects